SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals ($CRML) is trending as investors closely monitor developments in the rare earth element sector, particularly any movement on the Tanbreez project. Community discussions revolve around the potential impact of government policies and geopolitical factors on $CRML's prospects, alongside speculation regarding upcoming catalysts like the BFS report and potential partnerships.

What happens when you give Claude Code a blank webpage, and full control?

The Best Website Ever

BWE is trending negatively as the community expresses concerns about potential scams, rug pulls, and heavy shorting activity. Sentiment suggests expectations for continued downward movement, with many anticipating further drops and labeling the crypto as 'trash' and a 'scam company.' Talk of an impending bear market and potential dilution adds to the negative outlook.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending downwards amid concerns about a lowered revenue forecast due to data center delays, sparking discussions about the AI infrastructure sector's growth and profitability. Community members are debating whether this drop is an overreaction and a buying opportunity, or a sign of deeper issues like debt and market manipulation. Some are pointing fingers at a specific data center provider, while others are comparing $CRWV to competitors and discussing potential government intervention in AI infrastructure.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as investors digest its earnings report, a new $3 billion Meta contract, and news of a potential share dilution. Community members are debating the significance of the Meta deal and the company's growth prospects amid discussions about an AI bubble and comparing NBIS to competitors like CRWV. The stock's volatility and future potential in the AI infrastructure space remain key talking points.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the stock price hits a 16-month high, fueled by Citigroup increasing its stake and optimism around the upcoming R2 SUV. The community is buzzing about the potential for further gains and comparing Rivian's trajectory to Tesla's, while also debating the impact of the CEO's new performance-based compensation package. Some are seeing a breakout pattern and anticipating a move towards higher price targets.

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

LFS is trending due to a massive intraday surge, with traders actively discussing the reasons behind the sudden spike, including potential news catalysts or a possible short squeeze. The stock's impressive move is drawing attention to potential multi-day runner status, while some traders are looking for similar plays or sympathy stocks. Community members are debating whether it's too late to enter, while others are pointing to a potential pump and dump scenario.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is trending as investor sentiment shifts following news of expansion into additional European markets and recent focus list addition by Morgan Stanley. The community is also discussing Xpeng's innovative advancements in AI-integrated robotics and its potential to disrupt the EV and autonomous driving sectors. Many see the current valuation as heavily discounted compared to competitors like Tesla, highlighting the potential for significant growth.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation of a potential partnership with United Health and buyout offers, fueled by recent activity in the weight loss drug sector. Community discussions highlight the potential of Viking's GLP/GIP drug, VK2735, and its competitive edge over existing treatments. Positive sentiment surrounds the stock's potential, with some suggesting it is undervalued, while others remain cautious, noting the company's history.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as the company's analyst day sparks discussions around its long-term growth strategy and potential to capture a significant share of the expanding AI data center market. Community members are focused on AMD's projections for substantial revenue growth, particularly in the AI sector, and debate whether the stock is undervalued compared to competitors. Bullish sentiment is fueled by confidence in AMD's leadership and potential to challenge Nvidia in key markets.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CRMD is trending following a positive revenue update, leading to discussions about the company's growth trajectory and future potential. Community members are weighing in on the impact of the company's recent acquisition and expressing anticipation for upcoming earnings and catalysts, while also speculating on potential short squeezes. Some concerns persist around potential dilution and the company's strategy, with calls for stronger communication from management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bancroft Fund Ltd. (NYSE MKT: BCV) operates as a closed-end, diversified management company and invests primarily in convertible securities with the objectives of providing income and the potential for capital appreciation; which objectives the Fund considers to be relatively equal, over the long-term, due to the nature of the securities in which it invests.

Bancroft Fund Ltd

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with CoreWeave ($CRWV) stock on the post-earnings decline?

Current Price	$23.57
Prev Close	$23.67
Open	$23.66
Dividend Yield	7.63%
50-Day Moving Average	$22.55
Beta	0.62
Avg. Volume	28,355.87
PE Ratio	12.19

52-Week High	$23.88
52-Week Low	$15.63
Market Capitalization	N/A
EPS (Annual)	$2.11
Price to Book	1.22
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

BCV
Bancroft Fund Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest BCV News

BCVBancroft Fund Ltd.